Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Assembly Biosciences Q2 EPS $(1.98) Beats $(2.23) Estimate, Sales $8.53M Beat $5.96M Estimate

Author: Benzinga Newsdesk | August 08, 2024 05:53pm
Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(1.98) per share which beat the analyst consensus estimate of $(2.23) by 11.21 percent. This is a 48.97 percent increase over losses of $(3.88) per share from the same period last year. The company reported quarterly sales of $8.53 million which beat the analyst consensus estimate of $5.96 million by 43.17 percent.

Posted In: ASMB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist